A team of scientists say it is “beyond reasonable doubt” the Covid pandemic started with infected animals sold at a market, rather than a laboratory leak.

They were analysing hundreds of samples collected from Wuhan, China, in January 2020.

The results identify a shortlist of animals – including raremoved dogs, civets and bamboo rats – as potential sources of the pandemic.

Despite even highlighting one market stall as a hotspot of both animals and coronavirus, the study cannot provide definitive proof.

The samples were collected by Chinese officials in the early stages of Covid and are one of the most scientifically valuable sources of information on the origins of the pandemic.

Their analysis was published last year and the raw data made available to other scientists. Now a team in the US and France says they have performed even more advanced genetic analyses to peer deeper into Covid’s early days.

  • Roflmasterbigpimp@lemmy.world
    link
    fedilink
    arrow-up
    6
    ·
    edit-2
    2 months ago

    The samples were collected by Chinese officials in the early stages of Covid and are one of the most scientifically valuable sources of information on the origins of the pandemic.

    This Part makes me question things a bit. China is not really known for being honest about things happening in China.

    • Flying Squid@lemmy.world
      link
      fedilink
      arrow-up
      10
      ·
      2 months ago

      Questioning things is fine. On the other hand, it’s pretty hard to fake the ability to trace DNA to a specific market stall.

      On top of that, the person I replied to is not questioning. They’ve already decided it’s definitely a lab leak. See all of their other comments.

    • Knock_Knock_Lemmy_In@lemmy.world
      link
      fedilink
      arrow-up
      6
      ·
      edit-2
      2 months ago

      The study itself is quite balanced and honest about data collection. It doesn’t rule out a lab origin like the article claims.

      our study does not rule out human-to-animal transmission, as the sampling was carried out after the human infection within the market. Thus, the possibility of potential introduction of the virus to the market through infected humans, or cold-chain products, cannot yet be ruled out.